EFFECTS OF SGLT2 INHIBITOR, TOFOGLIFLOZIN ON BLOOD PRESSURE AND BAPWV IN RESISTANT HYPERTENSION WITH TYPE 2 DIABETES

Objective:We investigated the effects of SGLT2 inhibitor, Tofogliflozin on blood pressure (BP), baPWV in essential resistant hypertensive patients with type 2 diabetes.Design and method:The basal values of fasting plasma glucose (FPG), HbA1c, body weight, TG, HDL-C, LDL-C, uric acid (UA), eGFR, offi